Cellect Biotechnology (APOP) – Analyst Ratings
-
Cellect Biotechnology (APOP) PT Maintained at $14 at H.C. Wainwright on Scientific Collaboration with Dresden University denovoMATRIX
-
Cellect Biotechnology (APOP): Raising PT After Orphan Drug Status Granted - HC Wainwright
-
Back to APOP Stock Lookup